A REVIEW ON INTEGRATING SMART INHALERS FOR ASTHMA MANAGEMENT: A STEP TOWARD DIGITAL RESPIRATORY HEALTHCARE

Sterykos Elizabeth  Yaltang; Mausami Vaghela; Pwol  Freda Noro; Said Salim Said

doi:10.22270/ujpr.v11i2.1541

Sterykos Elizabeth Yaltang Marwadi University, Rajkot, Morbi highway, Gujrat, India.
Mausami Vaghela Marwadi University, Rajkot, Morbi highway, Gujrat, India.
Pwol Freda Noro Marwadi University, Rajkot, Morbi highway, Gujrat, India.
Said Salim Said Zanzibar Food and Drug Agency, Zanzibar, Tanzania.

10.22270/ujpr.v11i2.1541

Keywords:

Asthma, digital healthcare, medication adherence, respiratory medicine, smart inhalers

Abstract

Asthma remains one of the chronic respiratory disease that affects millions of individuals globally, over time, conventional inhalers have remained greatly useful in asthma control Nevertheless, there still exists a great deal of challenges in control of asthma including; lack of compliance, inappropriate inhalation methods, and lack of monitoring. Therefore, smart inhalers have introduced the union of digital technology and traditional inhaler devices, creating a viable solution and a future-proof solution through offering real-time feedback, dose tracking, and predictive analytics to aid patient adherence and optimize treatment results. The current review critically examines the current literature relating to the use of smart inhalers in the management of asthma, and their clinical benefits, drawbacks, and future perspectives. The objective is to combine critical findings and data regarding their efficacy in improving medication adherence, asthma control, treatment plans individualized and patient outcomes via AI driven insights and smartphone connectivity. However, despite its merits it also has limitations such as cost, user acceptability differing patient acceptability, cost-effectiveness and data privacy concerns. Future technologies, such as AI-powered inhalers and telemedicine platforms are set to revolutionize the digital respiratory healthcare systems. Lastly this review highlights the emerging role of pharmacists in using smart inhaler data to enable targeted interventions and drug management, with attention to long-term clinical effect and integration into digital respiratory healthcare systems with the promise of improving patient outcomes in asthma care.